ChromaDex Reports 2009 Financial Results

Wednesday, March 31, 2010 General News
Email Print This Page Comment
Font : A-A+

ChromaDex Corporation and Subsidiaries

Consolidated Statements of Operations

Years Ended January 2, 2010 and January 3, 2009

2009

2008

Sales

$         5,777,865

$       4,506,301

Cost of sales

3,736,435

3,274,800

Gross profit

2,041,430

1,231,501

Operating expenses:

Sales and marketing

829,969

720,519

General and administrative

2,104,193

2,574,985

2,934,162

3,295,504

Operating loss

(892,732)

(2,064,003)

Nonoperating (income) expenses:

Interest expense

17,090

70,079

Interest income

(2,254)

(29,606)

14,836

40,473

Net loss

$          (907,568)

$      (2,104,476)

Basic and Diluted loss per common share

$                 (0.03)

$                (0.07)

Basic and Diluted average common shares outstanding

28,838,216

28,312,934

See Notes to Consolidated Financial Statements.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook